6Lu Z, Kou W, Du B, et al. Effect of Xuezhikang, an extract from red yeast Chinese rice ,on coronary events in a Chinese population with previous myocardial infarction [ J ]. Am J Cardiol, 2008,101 : 1689 - 1693.
7He J,Gu D,Reynolds K,et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China[ J]. Circulation ,2004,110(4 ) :405 - 411.
8Sever PS, Dahlof B, Poulter NR, and stroke events with atorvastatin et al. Prevention of coronary in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes TriM-Lipid Lowering Arm (ASCOT-LLA) : a multicentre randomised controlled trial. Lancet, 2003,361:1149-1158.
9Kowala MC, Murugesan N, Tellew J, et al. Novel Dual Action AT1 and ETA Receptor Antagonists Reduce Blood Pressure in Experimental Hypertension. J Pharmacol Exp Ther, 2004,309: 275 -284.
10Ruiz-Opazo N, Hirayama K, Akimoto K, et al. Molecular characterization of a dual endothelin-1/angiotensin Ⅱ receptor. Mol Med, 1998, 4:96-108.
4Long SB, Blaha M J, Blumenthal RS, et al. Clinical utility of rosuvastatin and other statins for cardiovascular risk reduction among the elderly [ J ]. Clin Interv Aging,2011,6( 1 ) :27-35.
5Carnnitz W, Burdick MD, Strieter RM, et al. Dose-dependent effect of sta- tin therapy on circulating CXCL12 levels in patients with hyperlipidemia [ J]. Clin Transl Med,2012,1 ( 1 ) :23.
